Bharat Biotech said on Wednesday it had submitted data from its Covid-19 vaccine trial in children aged 2 to 18 years to the drug regulator, becoming the country's first company to have tested its shot in very young children.
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
The Drugs Controller General of India last month allowed vaccine maker Serum Institute to enroll kids aged 7 to 11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
So far, only drugmaker Zydus Cadila's DNA-based COVID-19 vaccine has received emergency use approval in India to be used in adults and children aged atleast 12 years.
Covid-19 Cases Rising Again: WHO Issues Urgent Alert On Potentially Severe Variants Covid-19 Still Driving High Mortality Rate In This Country Biden Returns To White House After Exiting US Presidential Race Kolkata Rape-Murder: Fractures, 150 mg Semen, Other Claims Denied By Cops LIVE: CBI Team At Kolkata Hospital For Digital Mapping Of Crime Scene Karnataka Chief Minister Siddaramaiah To Be Prosecuted In Land Scam Case Citroen Basalt (Tata Curvv Rival) Variant-Wise Prices Are Out: Full List US Supreme Court Keeps Block On Rules Protecting Transgender Students How Rupert Murdoch Helped Create A Monster - The Era Of Trumpism Track Latest News Live on NDTV.com and get news updates from India and around the world.